Correlation of B-type Natriuretic Peptide (BNP) with Left Ventricle Systolic Function Echocardiographic Parameters in Patients with Chronic Kidney Disease (CKD)

N. Prohić, H. Resić, G. Spasovski, F. Masnic, A. Bečiragić, Jelka Masin Spasovska, A. Ćorić
{"title":"Correlation of B-type Natriuretic Peptide (BNP) with Left Ventricle Systolic Function Echocardiographic Parameters in Patients with Chronic Kidney Disease (CKD)","authors":"N. Prohić, H. Resić, G. Spasovski, F. Masnic, A. Bečiragić, Jelka Masin Spasovska, A. Ćorić","doi":"10.2478/bj-2014-0021","DOIUrl":null,"url":null,"abstract":"Abstract Introduction. BNP plasma levels are significantly increased in heart failure and have an excellent negative predictive value for left ventricular dysfunction. Measurement of BNP level is useful for “screening” in high-risk populations. It is suitable for detection of left ventricular hypertrophy (LVH) and/or dysfunction and risk assessment in the sub-acute phase of acute myocardial infarction in hypertensive patients. The aim of our study was to find whether BNP may correlate with the left ventricular systolic function, i.e. its echocardiographic parameters in chronic kidney disease (CKD) patients. Methods. In a prospective study performed at the Department of Nephrology and Clinic for hemodialysis at the Clinical Center in Sarajevo we followed-up 80 patients stratified in three separate groups according to CKD stage (Stage III, IV and V) for two years, regardless of their cardiovascular symptoms. We analyzed levels of BNP before and after diuretic therapy or hemodialysis and echocardiographic characteristics of the left ventricle. Results. There was a strong negative correlation between BNP values and the size of the EF before (rho=−0.692, p<0.0001) and after diuretic therapy (rho=−0.683, p<0.0001) for patients in CKD stage III, stage IV (rho=−0.314, p>0.05) and after diuretic therapy (rho=−495, p<0.05) Similarly, a negative correlation was found for BNP and EF values before (rho=−0.432, p<0.05) and after hemodialysis (rho=−0.556, p<0.01) for stage V CKD. Conclusions. Our study confirmed that the value of BNP in CKD patients may represent a measure of left ventricular systolic function with a strong negative correlation with ejection fraction. BNP measurement is a reliable parameter for further follow-up and prognosis in patients with established left ventricular dysfunction, acute coronary syndrome and for estimation of the left ventricular dysfunction.","PeriodicalId":365549,"journal":{"name":"BANTAO Journal","volume":"58 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BANTAO Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/bj-2014-0021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Introduction. BNP plasma levels are significantly increased in heart failure and have an excellent negative predictive value for left ventricular dysfunction. Measurement of BNP level is useful for “screening” in high-risk populations. It is suitable for detection of left ventricular hypertrophy (LVH) and/or dysfunction and risk assessment in the sub-acute phase of acute myocardial infarction in hypertensive patients. The aim of our study was to find whether BNP may correlate with the left ventricular systolic function, i.e. its echocardiographic parameters in chronic kidney disease (CKD) patients. Methods. In a prospective study performed at the Department of Nephrology and Clinic for hemodialysis at the Clinical Center in Sarajevo we followed-up 80 patients stratified in three separate groups according to CKD stage (Stage III, IV and V) for two years, regardless of their cardiovascular symptoms. We analyzed levels of BNP before and after diuretic therapy or hemodialysis and echocardiographic characteristics of the left ventricle. Results. There was a strong negative correlation between BNP values and the size of the EF before (rho=−0.692, p<0.0001) and after diuretic therapy (rho=−0.683, p<0.0001) for patients in CKD stage III, stage IV (rho=−0.314, p>0.05) and after diuretic therapy (rho=−495, p<0.05) Similarly, a negative correlation was found for BNP and EF values before (rho=−0.432, p<0.05) and after hemodialysis (rho=−0.556, p<0.01) for stage V CKD. Conclusions. Our study confirmed that the value of BNP in CKD patients may represent a measure of left ventricular systolic function with a strong negative correlation with ejection fraction. BNP measurement is a reliable parameter for further follow-up and prognosis in patients with established left ventricular dysfunction, acute coronary syndrome and for estimation of the left ventricular dysfunction.
慢性肾病(CKD)患者b型利钠肽(BNP)与左心室收缩功能超声心动图参数的相关性
摘要介绍。BNP血浆水平在心力衰竭时显著升高,对左心室功能障碍有极好的阴性预测价值。BNP水平的测量对高危人群的“筛查”是有用的。适用于高血压患者急性心肌梗死亚急性期左心室肥厚(LVH)和/或功能障碍的检测及风险评估。我们研究的目的是发现BNP是否与慢性肾脏疾病(CKD)患者的左心室收缩功能相关,即其超声心动图参数。方法。在萨拉热窝临床中心肾内科和血液透析诊所进行的一项前瞻性研究中,我们根据CKD分期(III期、IV期和V期)将80例患者分为三组,随访两年,无论其心血管症状如何。我们分析了利尿剂治疗或血液透析前后的BNP水平和左心室超声心动图特征。结果。在利尿剂治疗前(rho= - 0.692, p0.05)和利尿剂治疗后(rho= - 495, p<0.05) BNP值与EF值呈显著负相关。同样,在V期CKD治疗前(rho= - 0.432, p<0.05)和血液透析后(rho= - 0.556, p<0.01) BNP值与EF值呈显著负相关。结论。我们的研究证实,慢性肾病患者的BNP值可能代表左心室收缩功能的一种测量,与射血分数呈强烈的负相关。BNP测量是确定左心室功能障碍、急性冠状动脉综合征患者进一步随访和预后的可靠参数,也是左心室功能障碍评估的可靠参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信